Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature DNA Labels to Protect Pharmaceutical Supply Chains
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today the signing of a Master Services Agreement with Germany-based Schreiner Group, an award-winning 68-year-old company specializing in innovative, functional labels and integrated security solutions across many industries, including the Pharmaceutical Industry through its Schreiner MediPharm business unit.
Applied DNA will supply its SigNature DNA forensic molecular tag with Beacon screening feature for Schreiner MediPharm’s high-end security label portfolio within the Pharmaceutical Industry for product and brand protection of its customers’ supply chains. Schreiner MediPharm will also provide authentication services to its customers using the Applied DNA SigNify portable DNA readers now in use at the Schreiner ProSecure competence center, providing security technologies and services to Schreiner MediPharm as well as Schreiner Group’s other business units.
In a joint development, SigNature DNA and Beacon were integrated in Schreiner MediPharm’s security label concepts and processes. These were validated over the last 18 months during which time the labels have undergone exhaustive environmental and reliability testing by both partners.
Dr. James Hayward, President and CEO of Applied DNA, said, “Schreiner MediPharm is an industry leader who brings top notch science and engineering to its pharmaceutical label portfolio with a spirit of innovation. Given the reported and continued high incidence rate of counterfeits within the pharmaceutical supply chain, we firmly believe the forensic SigNature DNA-protected labels will be of significant value in ensuring authentic medicines reach patients.”
Dr. Nadine Lampka, Product Manager Pharma-Security at Schreiner MediPharm, said, “Integrating SigNature DNA in combination with Beacon in our functional pharma labels will be setting a new security standard in the pharmaceutical industry. DNA-Secure is extremely robust, flexible to integrate and allows both a quick in-field test and an ultimate forensic proof in the lab. It provides excellent value for money and complements our portfolio of integrated authentication features on the high-security end.”